ROSE Diagnostics appoints Dr. Samir Makani of Scripps Health to its Medical Advisory Board

Carlsbad, California – 12 March 2024

ROSE Diagnostics has appointed Dr. Samir Makani of Scripps Health to its Medical Advisory Board as a Key Opinion Leader. As Director, Interventional Pulmonology and Bronchoscopy at Scripps Encinitas (network partner at Coastal Pulmonary Associates), Dr. Makani is an expert in Interventional Pulmonology, Pulmonary Disease, and Critical Care Medicine.

Named as “Top Doc” in San Diego magazine “Physicians of Exceptional Excellence”, Dr. Makani will provide ROSE with expert knowledge on interventional medicine that will be used to continuously improve ROSE products and how they shape the patient journey. Receiving feedback about our products from key industry leaders is important to ROSE and our mission; what clinicians who will be using our products think is vital to its success.

ROSE is excited to look to the future with Dr. Makani and Coastal Pulmonology Associates’ participation in ROSE’s upcoming clinical study, “Specimen Collection Research Study” that will be fundamental in locking down it’s verifi™ LUNG Test performance metrics just ahead of our pilot and pivotal clinical studies we expect to launch in early 2025.

For further inquiries, please contact: info@rose-dx.com

About Coastal Pulmonary Associates, an affiliate of Scripps Institute Encinadas:

“We are north county’s Scripps Health partner offering comprehensive pulmonary and critical care services. Our board eligible/certified and ``San Diego Top Doctors`` awarded physicians have expertise in each of the subspecialties of pulmonary medicine including advanced lung disease, interventional pulmonology and sleep medicine.” (from https://coastalpulmonary.com).